151 related articles for article (PubMed ID: 31726220)
1. Parasitic load determination by differential expressions of 5-lipoxygenase and PGE2 synthases in visceral leishmaniasis.
Saini S; Singh B; Prakash S; Kumari S; Kureel AK; Dube A; Sahasrabuddhe AA; Rai AK
Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106390. PubMed ID: 31726220
[TBL] [Abstract][Full Text] [Related]
2. Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host.
Rouault E; Lecoeur H; Meriem AB; Minoprio P; Goyard S; Lang T
Parasitol Int; 2017 Feb; 66(1):933-939. PubMed ID: 27794505
[TBL] [Abstract][Full Text] [Related]
3. Preventive as well as therapeutic significances of linoleic acid in the containment of Leishmania donovani infection.
Saini S; Kottarath SK; Dinda AK; Dube A; Sahasrabuddhe AA; Thakur CP; Bhat M; Rai AK
Biochimie; 2020 Aug; 175():13-22. PubMed ID: 32439363
[TBL] [Abstract][Full Text] [Related]
4. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
[TBL] [Abstract][Full Text] [Related]
5. Organ-specific immune profiling of Leishmania donovani-infected hamsters.
Saini S; Singh B; Dube A; Sahasrabuddhe AA; Rai AK
Parasite Immunol; 2023 Mar; 45(3):e12964. PubMed ID: 36571298
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways.
Reiner NE; Malemud CJ
J Immunol; 1985 Jan; 134(1):556-63. PubMed ID: 3917283
[TBL] [Abstract][Full Text] [Related]
7. Leishmania donovani reduces the levels of retinoic acid-synthesizing enzymes in infected macrophages and favoring its own survival.
Verma P; Kureel AK; Saini S; Prakash S; Kumari S; Kottarath SK; Srivastava SK; Bhat M; Dinda AK; Thakur CP; Sharma S; Rai AK
Parasitol Res; 2019 Jan; 118(1):63-71. PubMed ID: 30338372
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.
Espitia CM; Saldarriaga OA; Travi BL; Osorio EY; Hernandez A; Band M; Patel MJ; Medina AA; Cappello M; Pekosz A; Melby PC
BMC Immunol; 2014 Nov; 15():38. PubMed ID: 25424735
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of infection homogeneity and impact of miltefosine treatment in a Syrian golden hamster model of Leishmania donovani and L. infantum visceral leishmaniasis.
Eberhardt E; Mondelaers A; Hendrickx S; Van den Kerkhof M; Maes L; Caljon G
Parasitol Res; 2016 Oct; 115(10):4061-70. PubMed ID: 27412759
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.
Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC
PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856
[TBL] [Abstract][Full Text] [Related]
13. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
Moulik S; Karmakar J; Joshi S; Dube A; Mandal C; Chatterjee M
Parasite Immunol; 2021 Jan; 43(1):e12783. PubMed ID: 32734677
[TBL] [Abstract][Full Text] [Related]
14. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
15. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes.
Mukherjee P; Ghosh AK; Ghose AC
Immunol Lett; 2003 Apr; 86(2):131-8. PubMed ID: 12644314
[TBL] [Abstract][Full Text] [Related]
16. Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB
Sorgi CA; Soares EM; Rosada RS; Bitencourt CS; Zoccal KF; Pereira PAT; Fontanari C; Brandão I; Masson AP; Ramos SG; Silva CL; Frantz FG; Faccioli LH
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165574. PubMed ID: 31666208
[TBL] [Abstract][Full Text] [Related]
17. Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum.
Figueiredo WME; Viana SM; Alves DT; Guerra PV; Coêlho ZCB; Barbosa HS; Teixeira MJ
Mem Inst Oswaldo Cruz; 2017 Aug; 112(8):561-568. PubMed ID: 28767981
[TBL] [Abstract][Full Text] [Related]
18. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
Melby PC; Chandrasekar B; Zhao W; Coe JE
J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the biological behaviour in hamster of two isolates of Leishmania characterized respectively as L. major-like and L. donovani.
Duarte MI; Laurenti MD; Andrade Júnior HF; Corbett CE
Rev Inst Med Trop Sao Paulo; 1988; 30(1):21-7. PubMed ID: 3222614
[No Abstract] [Full Text] [Related]
20. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
